APA (7th ed.) Citation

JA, A., H, S., C, B., MA, S., HJ, L., E, V. C., . . . B, M. (2006). A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane. Investigational new drugs, 24(5), 441. https://doi.org/10.1007/s10637-006-7304-8

Chicago Style (17th ed.) Citation

JA, Ajani, Safran H, Bokemeyer C, Shah MA, Lenz HJ, Van Cutsem E, Burris HA 3rd, Lebwohl D, and Mullaney B. "A Multi-center Phase II Study of BMS-247550 (Ixabepilone) by Two Schedules in Patients with Metastatic Gastric Adenocarcinoma Previously Treated with a Taxane." Investigational New Drugs 24, no. 5 (2006): 441. https://doi.org/10.1007/s10637-006-7304-8.

MLA (9th ed.) Citation

JA, Ajani, et al. "A Multi-center Phase II Study of BMS-247550 (Ixabepilone) by Two Schedules in Patients with Metastatic Gastric Adenocarcinoma Previously Treated with a Taxane." Investigational New Drugs, vol. 24, no. 5, 2006, p. 441, https://doi.org/10.1007/s10637-006-7304-8.